• Fintech Ecosystem Development seeks to offer a diverse portfolio of fintech-related products and services to consumers and businesses in Europe, South Asia, East Asia, Latin America, Africa, and the United States
• The company is looking to participate in the growing cashless payments space, where global payment transaction volumes are set to increase by almost 300% by 2030
• FEXD intends to acquire or merge with pioneering fintech companies with, among others, a large customer base and the potential to be scaled up to global markets
• By executing its growth strategy, the company looks to equip cashless societies with scalable access to payment technologies and solutions

Consumers around the world were embracing cashless payments even before the COVID-19 pandemic broke out, from tapping a sales terminal with a mobile phone in the U.S. to making QR code payments in China. As a result, professional services multinational PWC writes in a report that this shift from cash payments “might ultimately lead to a cashless global society.” In fact, their analysis shows that the global cashless payment volumes are set to increase from about 1 trillion transactions in 2020 to almost 1.9 trillion in 2025, representing a jump of over 80%. By 2030, it is anticipated that the volume will have shot up to almost 3 trillion, a three-fold increase (https://ibn.fm/KdEgh).

Emerging markets in the Asia-Pacific region and Africa are set to witness the fastest growth. “Asia-Pacific will grow fastest, with cashless transaction volume growing by 109% until 2025 and then by 76% from 2025 to 2030, followed by Africa (78%, 64%) and Europe (64%, 39%),” the report continues. These projections align with the most recent data from Southeast Asia compiled by the Thai office of multinational VISA Inc. (NYSE: V) (https://ibn.fm/NEDBf). Here, according to VISA, “93% of consumers use a multitude of cashless payment methods including cards, contactless cards and mobile contactless, mobile wallets, and QR code payments.”

Fintech Ecosystem Development (NASDAQ: FEXD), a company looking to develop a global financial technology ecosystem, with plans to offer a diverse portfolio of fintech-related products and services to consumers and businesses in Europe, South Asia, East Asia, Latin America, Africa, and the United States, is eyeing a share of this growth.

“We are seeking to acquire and merge with high growth global fintech acquisition targets primarily operating in South Asia with a high volume of customers and large network of agents. The target companies we plan to acquire and merge with are expected to help us grow to $1 billion and more in annual revenues, as part of the global fintech ecosystem we are developing,” reads FEXD’s website (https://ibn.fm/Fhlyh).

Strategic in its approach, FEXD is targeting country-based fintech pioneers with the potential to be scaled up to global markets; a shared interest in making an impact by taking mobile transaction services to largely underserved markets; attractive valuation; growth-oriented management; as well as fintech service providers that will benefit from integrating more advanced technologies and fintech companies with a large existing customer base.

According to consultancy firm Bain & Company, companies with some of the characteristics FEXD has identified represent the biggest opportunities for dealmakers. In a report discussing the areas where the bulk of dealmaking has shifted, Bain notes that target companies with, among others, cross-border payments capabilities and those whose payments capabilities can be integrated into software offerings are drawing the greatest level of interest (https://ibn.fm/ZTJjD).

So far, the company has entered into a business combination agreement with Mobitech International LLC (dba Afinoz), a limited liability company organized in the United Arab Emirates, pursuant to which FEXD will purchase Afinoz. Afinoz is an artificial intelligence-enabled digital lending platform used by India’s leading banks, non-banking financial companies, and fintech loan providers. The acquisition is, however, yet to be completed. Still, Dr. Saiful Khandaker, FEXD CEO, President, and Founder, is confident about the positive impact of such acquisitions on the company’s operations.

“These acquisitions give us a solid competitive position in the emerging Fintech 3.0 global markets and allow us to provide neo-banking services in the U.S., Mexico, Brazil, and India, with opportunities to expand our services to other countries in South and East Asia and Latin America,” said Dr. Saiful in a September 2022 press release announcing the business combination agreement (https://ibn.fm/yIFq6). “We aim to use emerging technologies such as blockchain, Web 3.0, Metaverse, and artificial intelligence to reduce costs and accelerate the processing of money transfers, loans, and other lifestyle services, which will benefit consumers and businesses in many countries.”

Through its growth strategy, centered around M&A, FEXD is looking to equip markets with scalable access to cashless payment technologies and solutions, contributing to and participating in the growth of cashless societies.

For more information, visit the company’s website at www.FintechEcoSys.com.

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

• Fragrance allergies affect 2M+ people across the US, symptoms include skin redness, burning sensations, eyelid tearing, and swelling
• Skylar hypoallergenic fragrance line offers a safe alternative that doesn’t contain any of the 36 known allergens or 1,300+ “questionable” ingredients found in most fragrances
• Starco Brands recently released Skylar’s “Boardwalk Delight” scent at Sephora, sells out after 10 days
• All 10 Skylar scents are available at 500+ Sephora retail locations and online

Fragrance allergies affect more than 2 million Americans, with symptoms that include skin redness, burning sensations, eyelid tearing, and swelling. Even simple sensitivities can trigger reactions like headaches, breathing difficulties, sneezing, and nasal congestion.

Starco Brands’ (OTCQB: STCB) Skylar hypoallergenic fragrance line provides a safe alternative that is hypoallergenic, safe for sensitive skin, cruelty-free, vegan, and without any of the 36 fragrance allergens or 1,300+ “questionable” ingredients found in many perfumes.

Starco Brands recently released “Boardwalk Delight” at Sephora, an industry-leading beauty retailer that offers ten Skylar scents at 500+ retail locations and online.

“Boardwalk Delight sold out at Sephora and on skylar.com within ten days of launching, proving that more and more consumers are seeking artfully crafted fragrances with safe ingredients,” said Sara Miranda, Skylar’s vice president of marketing. “We are proud to partner with Sephora to educate consumers on the importance of clean fragrance.”

Starco Brands, Inc. announced it acquired the clean beauty brand in January 2023 (https://ibn.fm/IzQE7). Under the agreement terms, Skylar operates as a separate business unit within Starco Brands.

“At Starco Brands, we invent and commercialize products that change behavior and spark excitement,” said Ross Sklar, Starco Brands’ founder and CEO. “We look forward to building upon the clean fragrance platform to introduce new, breakthrough products. With strong partners like Sephora and Nordstrom by our side, we know Skylar is well positioned to be the future of fragrance.”

Starco Brands is a modern-day invention factory that invents and acquires brands with behavior-changing technologies. The company first identifies whitespaces in eight core consumer categories, and then fills those gaps by either acquiring existing brands or leveraging its manufacturing network and R&D capabilities to invent new products.

Starco Brands revenues soared last year from $2 million to an impressive annual run rate of roughly $67 million. Other company offerings include Art of Sport – a premium body and skincare line co-founded by Kobe Bryant, Winona theater-style popcorn spray powered by air, and Soylent – a line of award-winning food products touted as the “world’s most perfect food.”

Most recently, Starco Brands launched Lime Whipshots^® – the latest flavor added to the iconic vodka-infused whipped cream product line featuring global artist and icon Cardi B (https://ibn.fm/7eIZ0). With over two million cans sold since its initial launch, Whipshots’ success is a testament to Starco Brands, Inc.’s winning strategy that combines manufacturing, distribution and marketing expertise to delight consumers with novel, unique products that spark excitement in the everyday.

For more information, visit the company’s website at www.StarcoBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to STCB are available in the company’s newsroom at https://ibn.fm/STCB

• Data443 recently announced the acquisition of certain assets from Israeli-based cyber-security firm, Cyren Ltd., previously a company listed on the Nasdaq stock exchange
• The deal will see Data443 acquire capabilities within three significant revenue segments: threat intelligence, URL categorization, and email security
• The acquisition marks a major milestone, providing Data443 with direct access to customers with previously contracted revenues of approximately $15 million with upside potential
• The acquisition follows Data443’s First Quarter 2023 results, which saw dramatic increases in revenues (+125% YoY) and gross margins (over a third to 85%), driving a remarkable 184% YoY surge in gross profit

Data443 Risk Mitigation (OTC: ATDS), a data security and privacy software company, provides organizations of all sizes with the necessary software and services required to secure their data across devices and databases. Today, with over 10,000 customers across over 100 countries, Data443 enables its client base to prioritize risk, identify security gaps, and implement effective data protection and privacy management strategies through the provision of a broad and comprehensive product suite.

Data443 recently announced that it was taking the next step in its corporate journey, acquiring select assets from Israeli cloud-based, internet security technology company, Cyren Ltd. (https://ibn.fm/jVw7B). The acquisition will broaden Data443’s data security and protection capabilities and further complement the company’s award-winning ransomware protection and recovery capabilities – helping propel Data443 to a competitive advantage within a rapidly expanding marketplace, boasting the likes of Crowdstrike, Google/Madiant, SentinelOne, Cisco and Microsoft. The transaction, which is expected to close in the third quarter of 2023, will enable Data443 to enhance its existing product portfolio and accelerate the development of next-generation solutions.

Jason Remillard, Data443’s CEO and founder commented on the exciting news, stating, “Cyren has been a leader in emerging and high-volume risk mitigation for some of the world’s largest name brand organizations we all use today. This business has a tremendous track record, providing fast-breaking threat detection services and threat intelligence to major firewall vendors, email providers and leading cybersecurity vendors, as well as other industries such as a gaming console manufacturer and the world’s largest shopping and e-commerce providers. Our goal is to expand beyond the OEM market into the larger enterprise market. The threat intelligence market is a massive opportunity, an $18 billion-plus market growing at a 20.3% CAGR.”

The deal, which will result in Data443 onboarding customers representing over $15 million in unaudited FY2022 revenue, will mark yet another milestone within Data443’s ongoing financial achievements. The company recently published impressive financial results for the first quarter of 2023, which included revenue growth of 125 percent year-over-year to $1,380,000, achieving gross margins of a stunning 85% – resulting in a remarkable 184 percent gross profit increase relative to the first quarter 2022 (https://ibn.fm/sENk8). Commenting on these results, Remillard said,” These impressive results are a testament to our team’s relentless drive, passion, and commitment to better serving our existing enterprise clients and expanding our market reach. Achieving 125% revenue growth from a year ago clearly indicates that our efforts are resonating with our clients and the trust they place in us.”

The addition of new products within Data443’s product offering has led to increased customer loyalty and retention rates; in addition to achieving a near unheard of 98 percent rate of customer renewals over the past year, the company recently announced several new contract renewals, including securing additional contracts from one of their largest fintech clients as well as from one of the ‘big four’ U.S.-based banks – further expanding the company’s revenue pipeline in years ahead. Remillard added that “Our high customer renewal rates and their eagerness to renew with larger and longer-term contracts has always been the ultimate vote of confidence in our company. We are proud of the relationships we have built with our customers and will continue to nurture these partnerships in the years to come.”

Data443 Risk Mitigation, Inc. (ATDS) Investor Relations
Matthew Abenante
ir@data443.com 
919-858-6542

For more information, visit the company’s website at www.Data443.com. 

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

Reg A sponsors and management, marketing consultants, structured finance investors, and deal advisors – all are invited to join The Reg A Conference June 30, 2023 at the Westchester Country Club in Rye, New York. This high-energy conference will bring private companies and finance experts together to promote discussion that can lead to deal making and to provide in-depth education regarding the increasingly popular Regulation A as a capital raising tool.

For executives and investors looking to raise capital at reduced cost – without leaping through the regulatory hoops of a traditional IPO – The Reg A Conference provides insight and education from thought leaders with years of experience at companies like Deloitte, Ernst & Young, Morgan Stanley, Woodruff Sawyer, and many more, along with unmatched opportunities to network with experts who get deals done.

Brought to you by DealFlow Events, The Reg A Conference offers unparalleled investment opportunities while attendees enjoy a comfortable environment for doing business, featuring indoor and outdoor event spaces in luxurious surroundings.

Expert speakers and panelists have deep experience in Regulation A offerings and will provide valuable insight into how they work: what’s involved, the rules, timelines, fees and case examples of actual results.

Connecting the Reg A community

Since its inception in 2015, Regulation A provides an indemnity from registration obligations for businesses that want to raise money through a public offering of securities. Regulation A has two tiers of public offerings. Each tier involves different reporting needs, as well as separate limits for the value of securities that can be sold in any given year. It is one of the most cost-effective ways of raising capital that small to medium-sized businesses can use to ramp up their growth and accelerate their success.

You don’t want to miss out.

To learn more, visit https://ibn.fm/n2LIh

• Lexaria just announced additional findings from its HYPER-H21-4 human clinical study, highlighting significant reductions in several pro-inflammatory biomarkers associated with cardiovascular disease
• This has been termed as “the most convincing evidence in humans,” ultimately showcasing the potential of the company’s patented DehydraTECH(TM)-processed CBD
• Other third-party research studies have failed to demonstrate a sustained decrease in resting blood pressure with oral CBD dosing. More so, none have yielded evidence of the anti-inflammatory actions of CBD until Lexaria’s HYPER-H21-4 human clinical study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced additional findings from its HYPER-H21-4 human clinical study that sought to explore the potential of its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) in reducing blood pressure (“BP”). Of note was the demonstration of significant reductions in several pro-inflammatory biomarkers associated with cardiovascular disease (“CVD”) in what was described as “the most convincing evidence in humans” of the anti-inflammatory actions of CBD.

“There is some pre-clinical evidence for the anti-inflammatory actions of CBD, but this is likely the most convincing evidence in humans that I have ever seen,” noted Dr. Philip Ainslie, Cardiovascular Advisor to Lexaria and Lead Investigator of Study HYPER-H21-4 (https://ibn.fm/Cx0nx).

This finding adds to the success of the ambitious HYPER-H21-4, which successfully met all primary efficacy and safety objectives, with resting BP showing a significant reduction among hypertensive patients. Furthermore, this reduction in BP was sustained over a full 5-weeks of dosing, with no serious adverse events reported.  This built on the findings from the four previous human clinical studies conducted from 2018 to 2022, all of which have paved the way for Lexaria’s anticipated U.S. Food and Drug Administration (“FDA”) HYPER-H23-1 clinical study, its most ambitious yet.

Titled “A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Pharmacokinetics, and Pharmacodynamics of DehydraTECH-CBD, and Pharmacodynamics of DehydraTECH-CBD in Subjects with Stage 1 or Stage 2 Hypertension,” HYPER-H23-1 looks to build on all previous studies conducted by Lexaria thus far. It also plays an integral role as a lead-up to IND filing this summer, with hopes for FDA authorization within 60 days after that.

So far, only a handful of other research studies have investigated whether a sustained decrease in resting blood pressure is possible following multiple weeks of oral CBD dosing. However, none have been successful at achieving it. More so, none have yielded evidence of the anti-inflammatory actions of CBD, which shows the potential of Lexaria’s DehydraTECH-CBD.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

DGE invites business executives, women entrepreneurs, aspiring professionals, and industry leaders, to attend the 11th Advancing Women’s Leadership in Pharma & Healthcare event, to be held at The Bellevue Hotel, Philadelphia, PA, from September 19 – 21, 2023. The 11th edition of this transformative event provides an important platform to promote women’s empowerment.

The highly anticipated Advancing Women’s Leadership in Pharma & Healthcare event is dedicated to fostering gender diversity in male-dominant industries. This impactful and inspiring conference will feature an attractive lineup of keynote speakers and business leaders who will organize interactive workshops, sessions, and networking opportunities.

The event will feature thought-provoking case studies that will emphasize the success stories of women leaders. Attendees will get insights into the unique opportunities and challenges women often face in the healthcare and pharma industries. Esteemed business leaders and industry experts will share information on topics such as career development, leadership, mentorship, and diversity in the workplace.

Shaping the Future with Women’s Empowerment

The event aims to provide a holistic approach to professional growth while providing women with the skills, support, and tools they need to overcome business challenges and obstacles. The keynote presentations will reveal the key strategies to ensure business success and resilience in the pharmaceutical and healthcare sectors.

Focused on driving women’s careers, the skill-building workshops and hands-on sessions will focus on practical techniques for conflict resolution, effective negotiation, and women empowerment. By sharing personal experiences, influential business leaders will provide actionable strategies to drive change and handle key issues related to gender equality, diversity, and inclusion.

Offering a unique platform to connect and inspire, the 11th Advancing Women’s Leadership in Pharma & Healthcare event recognizes the importance of networking with industry leaders. The emerging women entrepreneurs will get expert guidance from veteran leaders and mentors. Attendees will get an opportunity to connect with business leaders and thrive in an environment of professional growth and knowledge sharing.

To learn more, please visit https://ibn.fm/nIBgE.

SPAC executives, brokerage firms, institutional investors, investment bankers and fund managers are invited to attend the SPAC Conference 2023 presented by DealFlow Events, to be held at the Westchester Country Club, Rye, New York from June 28-29, 2023.

As the largest forum for networking and discussion of special purpose acquisition companies, The SPAC Conference 2023 delivers the most reliable and up-to-date information required to thrive in the challenging SPAC market. The conference includes a private meeting space available throughout the event for company executives interested in consulting with institutional investors and management teams.

For private companies considering going public via a SPAC merger, the SPAC Conference 2023 will offer an unmatched opportunity to network with the leading deal-makers in the business. At this two-day event, key advisors, private equity firms, and corporate management teams will get an inclusive update on the state of the market from industry leaders.

Paving the Way to Growth Capital and Liquidity

The SPAC process continues to be an effective way to take a developing company public while avoiding the complications and costs associated with a traditional IPO. This is especially true today due to investor uncertainties created by a rapidly shifting equities market. SPACs continue to represent an important opportunity for those who know how best to utilize them. The SPAC Conference delivers cutting-edge insights into how to use this opportunity to meet your investment liquidity or corporate growth objectives.

Offering the largest gathering of management teams, investors, and bankers, this best-in-class conference includes one-on-one meetings that attendees can easily schedule through their event app, enabling participants to connect with SPAC experts before the event even starts, then converse face-to-face in private meeting areas. Conference-goers can count on the best networking opportunities to maximize their business development in the luxurious setting of the Westchester Country Club.

Our conference agenda, which includes the full line-up of speakers scheduled to present, is now available at https://spacconference.com/agenda/. The list includes industry leaders and executives from such companies as Deloitte, Loeb & Loeb, Withum, Laurel Hill, and Woodruff Sawyer.

To learn more, visit https://ibn.fm/NSIzp.

• FuelPositive recently announced a non-brokered private placement to raise up to $7.5 million, which is active now
• According to the company, net proceeds from the placement will be directed toward further development of demonstration systems for its on-site green ammonia production systems as well as working capital requirements
• As of early May, commissioning of the first farm-ready demonstration unit was nearing completion, with the company having kicked off production of its first commercial systems
• FuelPositive will deliver the demonstration system to a farm in Manitoba, Canada, and expects to gather real-time usage data that will shape future systems being built concurrently with the initial demonstration system

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a green technology company committed to developing commercially viable and sustainable onsite containerized green ammonia production systems, announced plans to raise up to $7.5 million by way of a non-brokered private placement. The net proceeds from this placement, the company said, will be channeled toward further development of demonstration systems for its green ammonia production solution, general working capital, and payment of services provided to FuelPositive in the ordinary course of business (https://ibn.fm/0ozaW).

“We anticipate that the enhanced liquidity resulting from this offering will contribute to greater growth for the company. The company’s pioneering green ammonia technology and decentralized business model hold immense potential to reshape the ammonia industry, fostering a greener future for generations to come. The net proceeds from this financing will help ensure FuelPositive’s leadership and ‘first-mover’ position in the multi-billion dollar sustainable and green ammonia industry,” said Ian Clifford, FuelPositive’s Board Chair and CEO.

The placement will consist of up to 115,384,615 units of the company, each priced at $0.065. Each unit comprises one common share of the company and one common share purchase warrant, allowing holders to purchase an additional common share at an exercise price of $0.09 within 36 months following the closing date of the placement. If the volume-weighted average closing price of FuelPositive’s common shares on the TSX Venture Exchange exceeds $0.40 for ten consecutive trading days, FuelPositive may choose to accelerate the expiry date of the warrants to 30 days after a public announcement of the election.

According to Clifford, the placement incorporates the newly implemented Listed Issuer Financing Exemption (“LIFE”), allowing both accredited and non-accredited investors to participate equally in the company’s financings. FuelPositive also announced that the securities issued in the placement pursuant to LIFE would not be subject to a hold period per Canadian securities law, while all other securities would be subject to a statutory hold period of four months and one day following issuance.

The upcoming placement is expected to support FuelPositive’s efforts to revolutionize the green ammonia industry by commercializing production solutions to produce green ammonia when and where it’s needed. Already, the company has begun running the final commissioning of the first farm-ready demonstration system, a production unit capable of producing300 kg per day of green anhydrous ammonia or a little over 100 metric tons per year, according to a May 2 news release (https://ibn.fm/g2lvf). Aptly named the FP300 model, this system is set to be delivered to the 11,000-acre crop farm of Tracy and Curtis Hiebert, where it will be heavily monitored for a full year, with the results shaping future systems being built concurrently with the initial demonstration system.

FuelPositive’s partnership with the Hieberts also includes a provision that may see the company piloting up to three versions of the demonstration systems on the farm (https://ibn.fm/SjRCq). The planned financing will, therefore, be integral in helping the company achieve this and other targets.

In addition to reporting that the final commissioning is underway, FuelPositive also announced it had started production of its first commercial systems. Having successfully met its planned pre-sales capacity of 30 units, the company plans to deliver the first batch of FP300 commercial systems beginning in 2024.

FuelPositive also announced its latest model, the FP1500, a turnkey system that upsizes the daily output of green anhydrous ammonia to 1,500 kg. or 500 metric tons per year.   According to the company, the decision to offer this larger system was influenced by customer demand from its pre-sales campaign. “Multiple end-users in various sectors, including farms of 10,000+ acres, have indicated the immediate need of FuelPositive systems of this scale and configuration. The FP1500 will answer this larger scale, onsite need,” explained Clifford.

For more information, visit the company’s website at www.FuelPositive.com.

NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Quantum computing can be a tool to help enterprises navigate the ongoing disruption and complexity of today’s business world
• Quantum adoption is expected to grow substantially over next 15-30 years, practical quantum solutions are already here, and demand for quantum-ready talent is rapidly accelerating
• Governments around the world have developed quantum adoption and investment strategies

As businesses encounter challenging computational problems that classical computers are ill-equipped to solve efficiently, or at all, the value of quantum computing is becoming increasingly apparent. Quantum can be used to tackle data-intensive computations in the areas of logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection, financial modeling, and more, and businesses are planning to increase their near-term commitments to this nascent technology, per research from Hyperion Report.

In this context, business leaders should embrace a “quantum mindset” in order to more effectively navigate today’s ongoing disruptions and complexity, according to D-Wave Quantum (NYSE: QBTS) President and CEO Dr. Alan Baratz. In a recent article published on LinkedIn entitled Shifting to Quantum Mindset: Why the Time is Now, Baratz explains why he believes quantum computing is here to stay. He outlines how quantum computing is progressing on multiple fronts, generating significant market potential and talent demand, amid increasing business and government investments in the technology on a worldwide basis (https://ibn.fm/kNSo5).

“The imperative is to adopt a quantum mindset that is ever-present,” Baratz states. “Now is the time to bring quantum to the forefront of decision-making when it comes to tech investment, business operations, national and global competitiveness, and workforce development.”

With quantum popularity increasing, so does the need for talent capable of working with it. Although quantum physicists are a part of the rapidly developing technological landscape, anyone with a computer science background who can code in Python can get started working with quantum.

As various governments map out national quantum strategies and increase funding, they are also targeting quantum education and building quantum-hybrid solutions to solve public sector challenges. Countries including the UK, Canada, France, and India have recently shared updated quantum strategies that map out adoption and investment plans, showing their long-term commitments to the technology.

According to Boston Consulting Group, the quantum computing market will grow to between $450 billion and $850 billion over the next 15 to 30 years (https://ibn.fm/ZKwEn). Hyperion Research estimates that 80% of quantum early adopters are planning to increase their commitment to quantum in the next two or three years, with one-third of them expected to invest at least $15 million in quantum (https://ibn.fm/n2aGv).

D-Wave is working with customers to build commercial quantum-hybrid applications today. D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used by some of the world’s most advanced enterprises. These customers include blue-chip industry leaders such as Volkswagen, Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, Accenture, NEC Corporation, Pattison Food Group, DENSO, and Lockheed Martin.

For more information, visit the company’s website at www.DWaveQuantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward-Looking Statements

This article contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which statements are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Forward-looking statements in this article include, but are not limited to, statements regarding the release and performance of the Advantage2 processor. We cannot assure you that the forward-looking statements in this article will prove to be accurate. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks; customer acceptance of our products and services; and the uncertainties and factors set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the registration statement on Form S-1 filed by the Company with the SEC on February 13, 2023, as well as factors associated with companies, such as D-Wave, that are engaged in the business of quantum computing, including anticipated trends, growth rates, and challenges in those businesses and in the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and or timing thereof; the performance of our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; the risk that our securities will not maintain the listing on the NYSE; changes in applicable laws and regulations; the effect of pandemics, geopolitical events, natural disasters, wars, or terrorist acts on our business or the economy in general; and the impact of inflation. Furthermore, if the forward-looking statements contained in this article prove to be inaccurate, the inaccuracy may be material. In addition, you are cautioned that past performance may not be indicative of future results. In light of the significant uncertainties in these forward-looking statements, you should not place undue reliance on these statements in making an investment decision or regard these statements as a representation or warranty by any person we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this article represent our views as of the date of this article. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this article.

• Methane is believed to cause climate change by trapping 86 times more heat in the atmosphere than carbon dioxide
• EVGIF advances RNG technology that negates the effects of methane while combatting carbon dioxide production caused by burning natural gas
• The RNG production process produces biogas that can be refined and purified to create pipeline-quality RNG, which can be injected into current networks
• EverGen aims to create an RNG network comprising 20+ facilities across Canada within five years

Methane is released while producing and transporting coal, natural gas, and oil. As a result, climate justice activists believe methane causes climate change by trapping 86 times more heat in the atmosphere than carbon dioxide alone (https://ibn.fm/M80Wk). Fortunately, EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), a Canadian renewable energy company, offers a solution through renewable natural gas (“RNG”) technology that negates the effects of methane while combatting carbon dioxide production associated with burning natural gas.

Experts from the World Economic Forum believe that methane emissions must drop to reach climate goals (https://ibn.fm/bErq9). According to the organization, methane emissions caused roughly 30% of global temperature increases since industrialization, and the problem is getting worse as emissions reach record levels.

RNG technology provides a solution that is more than just carbon-neutral – it’s carbon negative due to its ability to remove methane that otherwise would be produced when organic matter decomposes. The RNG production process leverages a process called anaerobic digestion that uses microorganisms to break down organic materials such as sewage sludge, organic waste, and animal manure in an enclosed, oxygen-free container (https://ibn.fm/FZe1A). The process then creates two primary products: digestate – a by-product that can be used as crop fertilizer, and biogas – a renewable source of methane gas.

Biogas can be refined and purified to create RNG – a pipeline-quality gas that can be injected into existing networks. EverGen aims to develop such a network comprising 20+ facilities within five years by acquiring, managing, and developing RNG and waste-to-energy projects nationwide.

Current projects in the company’s portfolio include Fraser Valley Biogas, Sea to Sky Soils, and Net Zero Waste Abbotsford in British Columbia, and a 67% stake in Alberta-based GrowTEC. Across the country in Ontario, EverGen has a 50% stake in Project Radius – a portfolio of three large, on-farm, and late-stage development projects that can potentially produce up to 1.7 million GJ of RNG annually.

The company is based in British Columbia – a province that actively takes action to reduce overall greenhouse gas emissions by supporting projects that displace equivalent volumes of traditional natural gas with carbon-neutral RNG. “The more RNG we have, the less conventional natural gas we need,” said Jenelle De La Cour, a manager of renewable gas accounts with FortisBC (https://ibn.fm/cr9bd). “Every RNG project is a win for climate action.”

EverGen leads RNG adoption in Canada with a portfolio of carbon negative RNG projects across the country. The company is committed to unlocking the power of carbon negative RNG to combat climate change, improve sustainability, and help reach worldwide emission targets.

For more information, visit the company’s website at www.EverGenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF